<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="to evaluate their match with seasonal vaccine strains. Methods: A" exact="total" post="of 7882 respiratory specimens from patients with influenza-like illness"/>
 <result pre="match with seasonal vaccine strains. Methods: A total of 7882" exact="respiratory" post="specimens from patients with influenza-like illness (ILI), were collected"/>
 <result pre="(ILI), were collected by regional sentinel practitioners and hospital physicians." exact="Viral" post="investigations were conducted by rRT-PCR assay. Genetic characterization was"/>
 <result pre="ranged between 28.9% (2013-2014) and 66.8% (2012-2013). Co-circulation of IVs" exact="type A" post="and type B was observed in all seasons, although"/>
 <result pre="(2013-2014) and 66.8% (2012-2013). Co-circulation of IVs type A and" exact="type B" post="was observed in all seasons, although with a different"/>
 <result pre="and 2014-2015 seasons. During 2015-2016, 2016-2017 and 2017-2018 seasons a" exact="complete" post="or nearly complete mismatch between the predominant influenza B"/>
 <result pre="During 2015-2016, 2016-2017 and 2017-2018 seasons a complete or nearly" exact="complete" post="mismatch between the predominant influenza B lineage of IVs"/>
 <result pre="complete mismatch between the predominant influenza B lineage of IVs" exact="type B" post="circulating and vaccine B lineage occurred. Conclusions: This analysis"/>
 <result pre="strain mismatch Introduction Seasonal influenza is an acute, highly contagious" exact="viral" post="respiratory infection of great importance from clinical and epidemiological"/>
 <result pre="mismatch Introduction Seasonal influenza is an acute, highly contagious viral" exact="respiratory" post="infection of great importance from clinical and epidemiological point"/>
 <result pre="Introduction Seasonal influenza is an acute, highly contagious viral respiratory" exact="infection" post="of great importance from clinical and epidemiological point of"/>
 <result pre="allows them to escape the immunity that comes from prior" exact="infections" post="or vaccination (2). Because of this, seasonal epidemics recur"/>
 <result pre="comorbidity (1,3-9). Periodically, in the range of 10-40 years, IVs" exact="type A" post="caused pandemic events, due to the emergence of a"/>
 <result pre="(12) and at European level, by the European Centre for" exact="Disease" post="Prevention and Control (ECDC) (13). The national influenza surveillance"/>
 <result pre="IVs, analyse antigenic, genetic and biological characteristics, also including the" exact="susceptibility to" post="available antiviral drugs. Moreover, they work to recognize any"/>
 <result pre="available antiviral drugs. Moreover, they work to recognize any new" exact="viral" post="variants in order to implement the appropriate containment and"/>
 <result pre="each year until the 17th of the following year, perform" exact="respiratory" post="samples from patients with a clinical presentation of influenza-like"/>
 <result pre="by the regional influenza reference Laboratory of Parma (29-31). Methods" exact="Respiratory" post="specimens from children and adults with a clinical presentation"/>
 <result pre="The &quot;Virocult�? diagnostic kit (MWE, England) and the commercial &quot;UTM" exact="Viral" post="Transport Media�? kit (Copan, Brescia, Italy) were used to"/>
 <result pre="&quot;Virocult�? diagnostic kit (MWE, England) and the commercial &quot;UTM Viral" exact="Transport" post="Media�? kit (Copan, Brescia, Italy) were used to collect"/>
 <result pre="Brescia, Italy) were used to collect the clinical samples (32)." exact="Viral" post="isolation was performed in Madin Darby Canine Kidney cells"/>
 <result pre="samples (32). Viral isolation was performed in Madin Darby Canine" exact="Kidney" post="cells (MDCK), and the presence of the virus was"/>
 <result pre="0,8% suspension in PBS of guinea pig red blood cells." exact="Viral" post="nucleic acid was extracted from respiratory specimens and from"/>
 <result pre="pig red blood cells. Viral nucleic acid was extracted from" exact="respiratory" post="specimens and from viral cell culture supernatant, using the"/>
 <result pre="Viral nucleic acid was extracted from respiratory specimens and from" exact="viral" post="cell culture supernatant, using the QIAamp Viral RNA Mini"/>
 <result pre="specimens and from viral cell culture supernatant, using the QIAamp" exact="Viral" post="RNA Mini Kit (Qiagen, Hilden, Germany), according to the"/>
 <result pre="with specific primer/probe sets targeting the matrix region of A" exact="type IV" post="and the nucleoprotein region of B type IV. For"/>
 <result pre="of A type IV and the nucleoprotein region of B" exact="type IV." post="For A type IV, samples were further subtyped using"/>
 <result pre="and the nucleoprotein region of B type IV. For A" exact="type IV," post="samples were further subtyped using specific primer/probe sets for"/>
 <result pre="guidelines (33-34). A representative number of influenza laboratory-confirmed specimens and" exact="viral" post="isolates, were sent to the NIC/ISS for antigenic characterisations"/>
 <result pre="the following five seasons, the proportion of positive samples was" exact="lower" post="(less than 50%) compared to the high number of"/>
 <result pre="antigenically indistinguishable from the vaccine strain A/Victoria/361/2011, but more genetically" exact="stable" post="for propagation and, for these reasons, recommended vaccine strain"/>
 <result pre="2014-2015 season A/H3N2 IVs presented with a mixed circulation of" exact="viral" post="variants antigenically distinct from the vaccine strain. The HA"/>
 <result pre="reference strain for the vaccine of 2018/2019 season. In Emilia-Romagna," exact="type B" post="IVs co-circulated with type A IVs in all seasons"/>
 <result pre="of 2018/2019 season. In Emilia-Romagna, type B IVs co-circulated with" exact="type A" post="IVs in all seasons and predominated over type A"/>
 <result pre="with type A IVs in all seasons and predominated over" exact="type A" post="during 2012-2013, 2015-2016, 2017-2018 seasons. With the exception of"/>
 <result pre="analysis of the HA gene sequence on a selection of" exact="type B" post="IVs circulating in 2010-2011 season, showed that most of"/>
 <result pre="for 2013/2014 vaccine. During 2015-2016, 2016-2017 and 2017-2018 seasons a" exact="complete" post="or nearly complete mismatch between the predominant influenza B"/>
 <result pre="During 2015-2016, 2016-2017 and 2017-2018 seasons a complete or nearly" exact="complete" post="mismatch between the predominant influenza B lineage and vaccine"/>
 <result pre="B lineage and vaccine B lineage occurred. In 2015-2016 season," exact="type B" post="IVs belonged to B/Vic lineage (clade 1A), related to"/>
 <result pre="recommended in the 2016-2017 trivalent vaccine formulation. During 2016-2017 season" exact="type B" post="IVs circulating in Emilia-Romagna belonged to B/Yam lineage (clade"/>
 <result pre="Emilia-Romagna was similar to that of the other regions (36-39)." exact="Type B" post="IVs co-circulated with type A IVs in all seasons."/>
 <result pre="of the other regions (36-39). Type B IVs co-circulated with" exact="type A" post="IVs in all seasons. With the exception of 2011-2012"/>
 <result pre="point of view, yearly variations by distribution and frequency of" exact="viral" post="types/subtypes were observed, as well as an alternation of"/>
 <result pre="Different considerations must be made for type A/H3N2 IVs and" exact="type B" post="IVs. The continuous and rapid evolution of A/H3N2 IVs"/>
 <result pre="different A/H3N2 IVs strains during the same season caused an" exact="incomplete" post="match between the vaccine strains and seasonal A/H3N2 IVs,"/>
 <result pre="≥65 years, more vulnerable to severe consequences of A/H3N2 IVs" exact="infection" post="(40-47). Furthermore, because of the presence of two genetically"/>
 <result pre="because of the presence of two genetically and antigenically distinct" exact="type B" post="IVs lineages, co-circulating in the same season with different"/>
 <result pre="circulate in the following season. During the study period, a" exact="complete" post="mismatch between the type B IVs circulating and the"/>
 <result pre="season. During the study period, a complete mismatch between the" exact="type B" post="IVs circulating and the vaccine strain, was observed in"/>
 <result pre="al.Viral etiology, seasonality and severity of hospitalized patients with severe" exact="acute" post="respiratory infections in the Eastern Mediterranean Region, 2007-2014PLoS ONE2017127e018095428704440"/>
 <result pre="etiology, seasonality and severity of hospitalized patients with severe acute" exact="respiratory" post="infections in the Eastern Mediterranean Region, 2007-2014PLoS ONE2017127e018095428704440 4PirallaALunghiGRuggieroLGirelloABianchiniSRovidaFet"/>
 <result pre="seasonality and severity of hospitalized patients with severe acute respiratory" exact="infections" post="in the Eastern Mediterranean Region, 2007-2014PLoS ONE2017127e018095428704440 4PirallaALunghiGRuggieroLGirelloABianchiniSRovidaFet al.Molecular"/>
 <result pre="hospitalized patients with severe acute respiratory infections in the Eastern" exact="Mediterranean" post="Region, 2007-2014PLoS ONE2017127e018095428704440 4PirallaALunghiGRuggieroLGirelloABianchiniSRovidaFet al.Molecular epidemiology of influenza B"/>
 <result pre="of observational studiesVaccine20173552152828024955 6SegaloffHEPetrieJGMaloshREChengCKMcSpaddenEJFerdinandsJMet al.Severe morbidity among hospitalized adults with" exact="acute" post="influenza and other respiratory infections; 2014–15 and 2015–16Epidemiol Infect2018146111350135829880077"/>
 <result pre="al.Severe morbidity among hospitalized adults with acute influenza and other" exact="respiratory" post="infections; 2014–15 and 2015–16Epidemiol Infect2018146111350135829880077 7MaloshREMartinETOrtizJRMontoASThe risk of lower"/>
 <result pre="other respiratory infections; 2014–15 and 2015–16Epidemiol Infect2018146111350135829880077 7MaloshREMartinETOrtizJRMontoASThe risk of" exact="lower" post="respiratory tract infection following influenza virus infection: A systematic"/>
 <result pre="respiratory infections; 2014–15 and 2015–16Epidemiol Infect2018146111350135829880077 7MaloshREMartinETOrtizJRMontoASThe risk of lower" exact="respiratory" post="tract infection following influenza virus infection: A systematic and"/>
 <result pre="2014–15 and 2015–16Epidemiol Infect2018146111350135829880077 7MaloshREMartinETOrtizJRMontoASThe risk of lower respiratory tract" exact="infection" post="following influenza virus infection: A systematic and narrative reviewVaccine201836114114729157959"/>
 <result pre="systematic and narrative reviewVaccine201836114114729157959 8IulianoADRoguskiKMChangHHMuscatelloDJPalekarRTempiaSet al.Estimates of global seasonal influenza-associated" exact="respiratory" post="mortality: a modelling studyLancet2018391101271285130029248255 9RathBPenttinenPIncidence, Severity and Impact of"/>
 <result pre="influenza virusNature20194597249931959 11RotaPAWallisTRHarmonMWRotaJSKendalAPNeromeKCocirculation of two distinct evolutionary lineages of influenza" exact="type B" post="virus since 1983Virology1990175159682309452 12World Health Organization Global Influenza Surveillance"/>
 <result pre="https://www.who.int/influenza/gisrs_laboratory/en/ (last accessed on 12 June 2019) 13European Centre for" exact="Disease" post="Prevention and Control (ECDC)Available from: https://ecdc.europa.eu/en/seasonal-influenza/surveillance-and-disease-data/facts-global-surveillance (last accessed on"/>
 <result pre="(last accessed on 12 June 2019) 14collab: European Centre for" exact="Disease" post="Prevention and Control (ECDC)National and global influenza surveillance system"/>
 <result pre="Infect Dis2016894295127061888 19EichnerMSchwehmMEichner, GerlierLDirect and indirect effects of influenza vaccinationBMC" exact="Infectious" post="Diseases201717130828441935 20KisslingEValencianoMLarrauriAOrosziBCohenJMNunesBet al.Low and decreasing vaccine effectiveness against influenza"/>
 <result pre="in the elderly population: Individual and general practitioner’s determinants in" exact="Central" post="Italy, Lazio region, 2016-2017 seasonVaccine2019doi: 10.1016/j.vaccine.2019.07.054. [Epub ahead of"/>
 <result pre="Preventive Medicine and Hygiene20044535156 31ChiapponiCEbranatiEParianiEFacciniSLuppiABaioniLet al.Genetic analysis of human and" exact="swine influenza" post="A viruses isolated in Northern Italy during 2010–2015Zoonoses Public"/>
 <result pre="protein of A/H1N1 seasonal influenza virusPLoS One20151050126742 51HswenYBrownsteinJSLiuJHawkinsJBUse of a" exact="Digital" post="Health Application for influenza surveillance in ChinaAm J Public"/>
</results>
